trending Market Intelligence /marketintelligence/en/news-insights/trending/oOzqm8-0RN8GDwagOBiFaA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Concert Pharmaceuticals director resigns

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Concert Pharmaceuticals director resigns

Concert Pharmaceuticals Inc. said Meghan FitzGerald resigned from the board, effective Dec. 11, due to other work commitments.

FitzGerald works in private equity and resigned her seat because one of her new portfolio companies invests in the biotechnology industry.

Lexington, Mass.-based Concert Pharmaceuticals operates as a clinical-stage biopharmaceutical company.